Literature DB >> 24867992

Eight more ways to deal with antibiotic resistance.

Matthew Metz1, David M Shlaes2.   

Abstract

The fight against antibiotic resistance must be strengthened. We propose actions that U.S. government agencies and private sector entities can take to build a more comprehensive effort. These actions can increase the viability of investing in new antibiotics, ensure the quality and stewardship of all antibiotics, and make responses to emerging resistance more informed. Success requires the thoughtful exercise of federal authority and a firm commitment to share data and reward developers for the value generated with new, life-saving antibiotics.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Mesh:

Substances:

Year:  2014        PMID: 24867992      PMCID: PMC4136015          DOI: 10.1128/AAC.02623-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  The shared antibiotic resistome of soil bacteria and human pathogens.

Authors:  Kevin J Forsberg; Alejandro Reyes; Bin Wang; Elizabeth M Selleck; Morten O A Sommer; Gautam Dantas
Journal:  Science       Date:  2012-08-31       Impact factor: 47.728

2.  Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.

Authors:  John J Engemann; Yehuda Carmeli; Sara E Cosgrove; Vance G Fowler; Melissa Z Bronstein; Sharon L Trivette; Jane P Briggs; Daniel J Sexton; Keith S Kaye
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

Review 3.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

4.  Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.

Authors:  Dongeun Yong; Mark A Toleman; Christian G Giske; Hyun S Cho; Kristina Sundman; Kyungwon Lee; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

5.  Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors.

Authors:  Jan A J W Kluytmans; Ilse T M A Overdevest; Ina Willemsen; Marjolein F Q Kluytmans-van den Bergh; Kim van der Zwaluw; Max Heck; Martine Rijnsburger; Christina M J E Vandenbroucke-Grauls; Paul H M Savelkoul; Brian D Johnston; David Gordon; James R Johnson
Journal:  Clin Infect Dis       Date:  2012-12-14       Impact factor: 9.079

6.  Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.

Authors:  Rebecca R Roberts; Bala Hota; Ibrar Ahmad; R Douglas Scott; Susan D Foster; Fauzia Abbasi; Shari Schabowski; Linda M Kampe; Ginevra G Ciavarella; Mark Supino; Jeremy Naples; Ralph Cordell; Stuart B Levy; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

7.  Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts.

Authors:  A E Mather; S W J Reid; D J Maskell; J Parkhill; M C Fookes; S R Harris; D J Brown; J E Coia; M R Mulvey; M W Gilmour; L Petrovska; E de Pinna; M Kuroda; M Akiba; H Izumiya; T R Connor; M A Suchard; P Lemey; D J Mellor; D T Haydon; N R Thomson
Journal:  Science       Date:  2013-09-12       Impact factor: 47.728

8.  Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC.

Authors:  Ewan M Harrison; Gavin K Paterson; Matthew T G Holden; Jesper Larsen; Marc Stegger; Anders Rhod Larsen; Andreas Petersen; Robert L Skov; Judit Marta Christensen; Anne Bak Zeuthen; Ole Heltberg; Simon R Harris; Ruth N Zadoks; Julian Parkhill; Sharon J Peacock; Mark A Holmes
Journal:  EMBO Mol Med       Date:  2013-03-25       Impact factor: 12.137

  8 in total
  8 in total

1.  Simple solutions reflect misunderstanding of animal antibiotic use.

Authors:  Richard Carnevale
Journal:  Antimicrob Agents Chemother       Date:  2015-01       Impact factor: 5.191

2.  Reducing the Bottleneck in Discovery of Novel Antibiotics.

Authors:  Marcus B Jones; William C Nierman; Yue Shan; Bryan C Frank; Amy Spoering; Losee Ling; Aaron Peoples; Ashley Zullo; Kim Lewis; Karen E Nelson
Journal:  Microb Ecol       Date:  2016-11-28       Impact factor: 4.552

3.  Antibiotic treatment enhances the genome-wide mutation rate of target cells.

Authors:  Hongan Long; Samuel F Miller; Chloe Strauss; Chaoxian Zhao; Lei Cheng; Zhiqiang Ye; Katherine Griffin; Ronald Te; Heewook Lee; Chi-Chun Chen; Michael Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

4.  Endless Resistance. Endless Antibiotics?

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Medchemcomm       Date:  2015-11-03       Impact factor: 3.597

Review 5.  Recent Advances in Antimicrobial Nano-Drug Delivery Systems.

Authors:  Tong-Xin Zong; Ariane Pandolfo Silveira; José Athayde Vasconcelos Morais; Marina Carvalho Sampaio; Luis Alexandre Muehlmann; Juan Zhang; Cheng-Shi Jiang; Shan-Kui Liu
Journal:  Nanomaterials (Basel)       Date:  2022-05-29       Impact factor: 5.719

6.  Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.

Authors:  Erika Leemans; Kiran V Mahasenan; Malika Kumarasiri; Edward Spink; Derong Ding; Peter I O'Daniel; Marc A Boudreau; Elena Lastochkin; Sebastian A Testero; Takao Yamaguchi; Mijoon Lee; Dusan Hesek; Jed F Fisher; Mayland Chang; Shahriar Mobashery
Journal:  Bioorg Med Chem Lett       Date:  2015-12-12       Impact factor: 2.823

7.  Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives.

Authors:  Zhonghui Zheng; Deping Du; Lili Cao; Jun Liu; Xiaofang Chen
Journal:  J Antibiot (Tokyo)       Date:  2016-04-27       Impact factor: 2.649

Review 8.  Veterinary Medicine Needs New Green Antimicrobial Drugs.

Authors:  Pierre-Louis Toutain; Aude A Ferran; Alain Bousquet-Melou; Ludovic Pelligand; Peter Lees
Journal:  Front Microbiol       Date:  2016-08-03       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.